BRIEF-Zomedica says files u.s. provisional patent application for novel pharmaceutical formulation
July 12 (Reuters) - Zomedica Pharmaceuticals
* Zomedica files u.s. Provisional patent application for novel pharmaceutical formulation
* Filed provisional application for patent with u.s. Patent and trademark office for a novel formulation of zm-006
* Opened its second investigational new animal drug application with u.s. Fda center for veterinary medicine for zm-006
* Application based on positive results from both in-vivo and in-vitro studies designed to address unique formulation requirements of companion animals
* Says concurrently it has opened its second investigational new animal drug application with u.s. fda center for veterinary medicine for zm-006 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.